

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.69923721 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.69081103 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.69081103 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.38396879 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.78503917 |
| 6 | leukocyte aggregation (GO:0070486) | 5.36107522 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.31789512 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.26263221 |
| 9 | negative T cell selection (GO:0043383) | 5.25578920 |
| 10 | negative thymic T cell selection (GO:0045060) | 5.21628121 |
| 11 | positive thymic T cell selection (GO:0045059) | 5.05486973 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.02748327 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.02748327 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 5.02748327 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 5.02748327 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 5.02748327 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.02748327 |
| 18 | detection of bacterium (GO:0016045) | 4.94489579 |
| 19 | detection of other organism (GO:0098543) | 4.90970484 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.83335800 |
| 21 | response to interleukin-15 (GO:0070672) | 4.72734084 |
| 22 | negative regulation of cell killing (GO:0031342) | 4.70700683 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.70700683 |
| 24 | B cell receptor signaling pathway (GO:0050853) | 4.65312580 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 4.53904276 |
| 26 | T cell migration (GO:0072678) | 4.43479693 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 4.41132976 |
| 28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.40524875 |
| 29 | thymic T cell selection (GO:0045061) | 4.38717276 |
| 30 | regulation of B cell differentiation (GO:0045577) | 4.38055489 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.37240413 |
| 32 | positive T cell selection (GO:0043368) | 4.31086449 |
| 33 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.17224499 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 4.15621319 |
| 35 | T cell selection (GO:0045058) | 4.12967087 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 4.08056059 |
| 37 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.95965777 |
| 38 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.94060026 |
| 39 | mast cell activation (GO:0045576) | 3.93454251 |
| 40 | response to peptidoglycan (GO:0032494) | 3.90992497 |
| 41 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.88441422 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.87992051 |
| 43 | interferon-gamma production (GO:0032609) | 3.87778948 |
| 44 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.85135341 |
| 45 | detection of external biotic stimulus (GO:0098581) | 3.84744448 |
| 46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.84406277 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 3.81463286 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75865715 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.75236371 |
| 50 | negative regulation of phagocytosis (GO:0050765) | 3.73392936 |
| 51 | neutrophil activation (GO:0042119) | 3.67465308 |
| 52 | T cell receptor signaling pathway (GO:0050852) | 3.67254962 |
| 53 | T cell costimulation (GO:0031295) | 3.65263055 |
| 54 | lymphocyte costimulation (GO:0031294) | 3.60178700 |
| 55 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.59129223 |
| 56 | response to host immune response (GO:0052572) | 3.50844668 |
| 57 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.50844668 |
| 58 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.50298510 |
| 59 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.46751699 |
| 60 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.46286185 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 3.46065485 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.46034598 |
| 63 | ribosomal small subunit assembly (GO:0000028) | 3.44129687 |
| 64 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.43554481 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.43452161 |
| 66 | cellular response to zinc ion (GO:0071294) | 3.43062183 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.42119567 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.38978901 |
| 69 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.38595585 |
| 70 | detection of biotic stimulus (GO:0009595) | 3.34389776 |
| 71 | mast cell degranulation (GO:0043303) | 3.33548565 |
| 72 | mast cell activation involved in immune response (GO:0002279) | 3.33548565 |
| 73 | positive regulation of lamellipodium assembly (GO:0010592) | 3.33237626 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.33213425 |
| 75 | granulocyte activation (GO:0036230) | 3.33018511 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 3.30871659 |
| 77 | sequestering of actin monomers (GO:0042989) | 3.30314986 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.27611439 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.26096146 |
| 80 | response to host defenses (GO:0052200) | 3.23845174 |
| 81 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23845174 |
| 82 | response to host (GO:0075136) | 3.23845174 |
| 83 | tolerance induction (GO:0002507) | 3.21874388 |
| 84 | leukocyte degranulation (GO:0043299) | 3.21810419 |
| 85 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19742921 |
| 86 | NIK/NF-kappaB signaling (GO:0038061) | 3.18702103 |
| 87 | germinal center formation (GO:0002467) | 3.16683678 |
| 88 | positive regulation of interleukin-2 production (GO:0032743) | 3.15914571 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.14295716 |
| 90 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.11041829 |
| 91 | * T cell homeostasis (GO:0043029) | 3.10032022 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09289026 |
| 93 | response to type I interferon (GO:0034340) | 3.09272256 |
| 94 | leukocyte cell-cell adhesion (GO:0007159) | 3.08955462 |
| 95 | cellular extravasation (GO:0045123) | 3.08869984 |
| 96 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.08356194 |
| 97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.07817807 |
| 98 | negative regulation of innate immune response (GO:0045824) | 3.07644651 |
| 99 | type I interferon signaling pathway (GO:0060337) | 3.06135075 |
| 100 | cellular response to type I interferon (GO:0071357) | 3.06135075 |
| 101 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.06039991 |
| 102 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.04930292 |
| 103 | regulation of response to interferon-gamma (GO:0060330) | 3.04315032 |
| 104 | microglial cell activation (GO:0001774) | 3.03840159 |
| 105 | positive regulation of isotype switching (GO:0045830) | 3.03405142 |
| 106 | actin nucleation (GO:0045010) | 3.02073255 |
| 107 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.01049053 |
| 108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00892787 |
| 109 | respiratory burst (GO:0045730) | 3.00387198 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 2.99616949 |
| 111 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.98244764 |
| 112 | B cell mediated immunity (GO:0019724) | 2.96867781 |
| 113 | * lymphocyte homeostasis (GO:0002260) | 2.96811597 |
| 114 | myeloid dendritic cell activation (GO:0001773) | 2.96627997 |
| 115 | defense response to protozoan (GO:0042832) | 2.95959134 |
| 116 | regulation of antigen processing and presentation (GO:0002577) | 2.94670973 |
| 117 | response to protozoan (GO:0001562) | 2.94205036 |
| 118 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.93749611 |
| 119 | regulation of leukocyte degranulation (GO:0043300) | 2.93714688 |
| 120 | mature B cell differentiation (GO:0002335) | 2.93550157 |
| 121 | neutrophil mediated immunity (GO:0002446) | 2.92899917 |
| 122 | natural killer cell activation (GO:0030101) | 2.91053512 |
| 123 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.90797308 |
| 124 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90250201 |
| 125 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.89967537 |
| 126 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.89760634 |
| 127 | regulation of regulatory T cell differentiation (GO:0045589) | 2.89536221 |
| 128 | positive regulation of mast cell activation (GO:0033005) | 2.89246248 |
| 129 | viral transcription (GO:0019083) | 2.86026766 |
| 130 | positive regulation of lamellipodium organization (GO:1902745) | 2.85847905 |
| 131 | positive regulation of tolerance induction (GO:0002645) | 2.81173080 |
| 132 | positive regulation of granulocyte differentiation (GO:0030854) | 2.76589729 |
| 133 | lymph node development (GO:0048535) | 2.76458992 |
| 134 | cellular response to interferon-beta (GO:0035458) | 2.76173045 |
| 135 | natural killer cell differentiation (GO:0001779) | 2.75047977 |
| 136 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.74856401 |
| 137 | positive regulation of immunoglobulin production (GO:0002639) | 2.74026580 |
| 138 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.73368957 |
| 139 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.73368957 |
| 140 | T cell proliferation (GO:0042098) | 2.71984646 |
| 141 | * leukocyte homeostasis (GO:0001776) | 2.70044778 |
| 142 | translational termination (GO:0006415) | 2.69984087 |
| 143 | regulation of B cell mediated immunity (GO:0002712) | 2.69599604 |
| 144 | activated T cell proliferation (GO:0050798) | 2.69097881 |
| 145 | regulation of tolerance induction (GO:0002643) | 2.67907772 |
| 146 | mature B cell differentiation involved in immune response (GO:0002313) | 2.67755575 |
| 147 | regulation of isotype switching (GO:0045191) | 2.65911392 |
| 148 | megakaryocyte development (GO:0035855) | 2.65810086 |
| 149 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64110625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.28867003 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.41012052 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.40550314 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.08711243 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.67667891 |
| 6 | * MYC_22102868_ChIP-Seq_BL_Human | 3.45319175 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35929581 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.15252111 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.14970720 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.85931569 |
| 11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.68524955 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.67667697 |
| 13 | * MYB_26560356_Chip-Seq_TH2_Human | 2.64257291 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60968353 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55521746 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55237513 |
| 17 | * MAF_26560356_Chip-Seq_TH1_Human | 2.53418867 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.52947731 |
| 19 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.50640205 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50426012 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.44079004 |
| 22 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.32357355 |
| 23 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.32274212 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30999787 |
| 25 | * MYB_26560356_Chip-Seq_TH1_Human | 2.30829432 |
| 26 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.29076446 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20706256 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.20027884 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.13518407 |
| 30 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09432584 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08007957 |
| 32 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.07061986 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03912550 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.02914880 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00803472 |
| 36 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.00496122 |
| 37 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.99918253 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93631482 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82172070 |
| 40 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81669652 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.80382382 |
| 42 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78758860 |
| 43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.76984647 |
| 44 | MAF_26560356_Chip-Seq_TH2_Human | 1.75314542 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72279594 |
| 46 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71120978 |
| 47 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.70389846 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63274773 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56574296 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.50888064 |
| 51 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.50208808 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49821428 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49111863 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48873986 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47826759 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.45811571 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43099183 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43045038 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.43000148 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.41582286 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41280924 |
| 62 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32385933 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29702726 |
| 64 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.29186334 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28779547 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27552409 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27172527 |
| 68 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.26907869 |
| 69 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25477352 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24945172 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23942365 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.23185039 |
| 73 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22530635 |
| 74 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.22300666 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19015893 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17337697 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15836253 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14960404 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13611957 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13559814 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12698586 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12271836 |
| 83 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.12169040 |
| 84 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09386444 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09340871 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07336160 |
| 87 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.07232686 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06852245 |
| 89 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.06621590 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06157614 |
| 91 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.06110639 |
| 92 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04056837 |
| 93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03622401 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03095155 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01720324 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01634516 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01253342 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99904284 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98082205 |
| 100 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.96753864 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96290235 |
| 102 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95540055 |
| 103 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94996103 |
| 104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94775920 |
| 105 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94689637 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94648400 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94073288 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91688328 |
| 109 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.91199449 |
| 110 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91183622 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91162586 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90568968 |
| 113 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.90563914 |
| 114 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.90276142 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89876998 |
| 116 | P68_20966046_ChIP-Seq_HELA_Human | 0.89687111 |
| 117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87246511 |
| 118 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87119839 |
| 119 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.86943041 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86110692 |
| 121 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.86083380 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85945206 |
| 123 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.85114912 |
| 124 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.84907446 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 0.82512821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.40120815 |
| 2 | MP0005671_abnormal_response_to | 3.87117030 |
| 3 | MP0000685_abnormal_immune_system | 3.74327650 |
| 4 | * MP0003763_abnormal_thymus_physiology | 3.67888823 |
| 5 | MP0001800_abnormal_humoral_immune | 3.49404480 |
| 6 | MP0005387_immune_system_phenotype | 3.20830356 |
| 7 | MP0001790_abnormal_immune_system | 3.20830356 |
| 8 | MP0009785_altered_susceptibility_to | 3.12382510 |
| 9 | MP0002396_abnormal_hematopoietic_system | 3.03541816 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 2.96242069 |
| 11 | * MP0002452_abnormal_antigen_presenting | 2.93462059 |
| 12 | * MP0001819_abnormal_immune_cell | 2.91679884 |
| 13 | * MP0005000_abnormal_immune_tolerance | 2.90307712 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.88134328 |
| 15 | * MP0002723_abnormal_immune_serum | 2.87472823 |
| 16 | MP0003436_decreased_susceptibility_to | 2.79385787 |
| 17 | * MP0005025_abnormal_response_to | 2.66329542 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.56863188 |
| 19 | * MP0000716_abnormal_immune_system | 2.53984458 |
| 20 | MP0003303_peritoneal_inflammation | 2.46100491 |
| 21 | * MP0000689_abnormal_spleen_morphology | 2.35452505 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.31801669 |
| 23 | * MP0002419_abnormal_innate_immunity | 2.31763188 |
| 24 | MP0002405_respiratory_system_inflammati | 2.30848256 |
| 25 | * MP0002722_abnormal_immune_system | 2.30714821 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.27546743 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.17837253 |
| 28 | * MP0002429_abnormal_blood_cell | 2.15219365 |
| 29 | MP0001873_stomach_inflammation | 2.13733703 |
| 30 | * MP0000703_abnormal_thymus_morphology | 2.13292551 |
| 31 | MP0002006_tumorigenesis | 2.03827061 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 2.03058978 |
| 33 | MP0010155_abnormal_intestine_physiology | 2.02033436 |
| 34 | MP0006082_CNS_inflammation | 1.93225470 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.87756147 |
| 36 | MP0003866_abnormal_defecation | 1.84544272 |
| 37 | MP0003724_increased_susceptibility_to | 1.83243931 |
| 38 | MP0001853_heart_inflammation | 1.79344736 |
| 39 | MP0004947_skin_inflammation | 1.75589873 |
| 40 | * MP0001845_abnormal_inflammatory_respons | 1.75409519 |
| 41 | MP0002933_joint_inflammation | 1.64967833 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.60233061 |
| 43 | MP0005397_hematopoietic_system_phenotyp | 1.58298317 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.58298317 |
| 45 | MP0008260_abnormal_autophagy | 1.53941077 |
| 46 | MP0004510_myositis | 1.51079267 |
| 47 | MP0000490_abnormal_crypts_of | 1.44605343 |
| 48 | MP0003693_abnormal_embryo_hatching | 1.36141562 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.35775867 |
| 50 | MP0009278_abnormal_bone_marrow | 1.34023260 |
| 51 | MP0010094_abnormal_chromosome_stability | 1.31741942 |
| 52 | MP0000858_altered_metastatic_potential | 1.29230801 |
| 53 | MP0005310_abnormal_salivary_gland | 1.29208765 |
| 54 | MP0005451_abnormal_body_composition | 1.27769151 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.25487131 |
| 56 | MP0008469_abnormal_protein_level | 1.25161456 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.24328143 |
| 58 | MP0008057_abnormal_DNA_replication | 1.21471531 |
| 59 | MP0003077_abnormal_cell_cycle | 1.21318028 |
| 60 | MP0001533_abnormal_skeleton_physiology | 1.19668304 |
| 61 | MP0002277_abnormal_respiratory_mucosa | 1.11587585 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.05400616 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.02199001 |
| 64 | MP0003448_altered_tumor_morphology | 1.01528973 |
| 65 | MP0004883_abnormal_blood_vessel | 1.00615024 |
| 66 | MP0003172_abnormal_lysosome_physiology | 0.98556226 |
| 67 | MP0002132_abnormal_respiratory_system | 0.95635118 |
| 68 | MP0002095_abnormal_skin_pigmentation | 0.92940191 |
| 69 | MP0004957_abnormal_blastocyst_morpholog | 0.91638451 |
| 70 | MP0003111_abnormal_nucleus_morphology | 0.91184122 |
| 71 | MP0000015_abnormal_ear_pigmentation | 0.87898578 |
| 72 | MP0003075_altered_response_to | 0.86386021 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.85937881 |
| 74 | MP0008007_abnormal_cellular_replicative | 0.84517489 |
| 75 | MP0001851_eye_inflammation | 0.81291993 |
| 76 | MP0008058_abnormal_DNA_repair | 0.80624664 |
| 77 | MP0003690_abnormal_glial_cell | 0.80115064 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.80112122 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.75402848 |
| 80 | MP0009764_decreased_sensitivity_to | 0.74071229 |
| 81 | MP0000313_abnormal_cell_death | 0.72760760 |
| 82 | MP0005390_skeleton_phenotype | 0.72055596 |
| 83 | MP0009763_increased_sensitivity_to | 0.69472841 |
| 84 | MP0000343_altered_response_to | 0.68539401 |
| 85 | MP0010307_abnormal_tumor_latency | 0.68303866 |
| 86 | MP0001663_abnormal_digestive_system | 0.66763613 |
| 87 | MP0005164_abnormal_response_to | 0.64188960 |
| 88 | MP0005023_abnormal_wound_healing | 0.63045088 |
| 89 | MP0000604_amyloidosis | 0.61525147 |
| 90 | MP0008874_decreased_physiological_sensi | 0.60453048 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.59397499 |
| 92 | MP0000477_abnormal_intestine_morphology | 0.58819665 |
| 93 | MP0003806_abnormal_nucleotide_metabolis | 0.58394401 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.56531645 |
| 95 | MP0002693_abnormal_pancreas_physiology | 0.55997547 |
| 96 | MP0005166_decreased_susceptibility_to | 0.55122154 |
| 97 | MP0000350_abnormal_cell_proliferation | 0.53618826 |
| 98 | MP0004381_abnormal_hair_follicle | 0.52923526 |
| 99 | MP0006054_spinal_hemorrhage | 0.52837268 |
| 100 | MP0008873_increased_physiological_sensi | 0.52139256 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.49369782 |
| 102 | MP0002928_abnormal_bile_duct | 0.48904340 |
| 103 | MP0003828_pulmonary_edema | 0.48034015 |
| 104 | MP0004130_abnormal_muscle_cell | 0.47853920 |
| 105 | MP0008004_abnormal_stomach_pH | 0.47707967 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.46394428 |
| 107 | MP0000249_abnormal_blood_vessel | 0.45934075 |
| 108 | MP0003795_abnormal_bone_structure | 0.45731316 |
| 109 | MP0005381_digestive/alimentary_phenotyp | 0.45516600 |
| 110 | MP0003091_abnormal_cell_migration | 0.45462494 |
| 111 | MP0005076_abnormal_cell_differentiation | 0.45070435 |
| 112 | MP0000609_abnormal_liver_physiology | 0.44352362 |
| 113 | MP0001191_abnormal_skin_condition | 0.43974720 |
| 114 | MP0002083_premature_death | 0.42729165 |
| 115 | MP0003045_fibrosis | 0.42372647 |
| 116 | MP0003943_abnormal_hepatobiliary_system | 0.41063567 |
| 117 | MP0000371_diluted_coat_color | 0.40871904 |
| 118 | * MP0002136_abnormal_kidney_physiology | 0.40116571 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.39820563 |
| 120 | MP0008961_abnormal_basal_metabolism | 0.39648830 |
| 121 | MP0002009_preneoplasia | 0.39386096 |
| 122 | MP0001348_abnormal_lacrimal_gland | 0.38854728 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.37247446 |
| 124 | MP0009840_abnormal_foam_cell | 0.36421785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bronchitis (HP:0002837) | 5.21209895 |
| 2 | IgM deficiency (HP:0002850) | 5.07256724 |
| 3 | Chronic otitis media (HP:0000389) | 5.02324249 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.88766516 |
| 5 | T lymphocytopenia (HP:0005403) | 4.74489610 |
| 6 | Eczematoid dermatitis (HP:0000976) | 4.65737001 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 4.65625052 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.65410006 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.62072214 |
| 10 | Recurrent viral infections (HP:0004429) | 4.59261906 |
| 11 | Agammaglobulinemia (HP:0004432) | 4.56513954 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.54032443 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.38963703 |
| 14 | Abnormality of T cells (HP:0002843) | 4.26292878 |
| 15 | Myositis (HP:0100614) | 4.10069145 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 4.07839829 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.01723706 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 4.01723706 |
| 19 | Meningitis (HP:0001287) | 3.97588061 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.94845237 |
| 21 | Nasal polyposis (HP:0100582) | 3.82703194 |
| 22 | Cellulitis (HP:0100658) | 3.81873100 |
| 23 | IgG deficiency (HP:0004315) | 3.67531186 |
| 24 | Severe combined immunodeficiency (HP:0004430) | 3.66633557 |
| 25 | Thrombocytosis (HP:0001894) | 3.62379773 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.62326801 |
| 27 | B lymphocytopenia (HP:0010976) | 3.60149668 |
| 28 | Abnormality of B cell number (HP:0010975) | 3.60149668 |
| 29 | Inflammation of the large intestine (HP:0002037) | 3.53878508 |
| 30 | Combined immunodeficiency (HP:0005387) | 3.52941543 |
| 31 | Gastrointestinal inflammation (HP:0004386) | 3.50295553 |
| 32 | Thyroiditis (HP:0100646) | 3.44407925 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 3.43521330 |
| 34 | Recurrent sinusitis (HP:0011108) | 3.41578314 |
| 35 | Recurrent skin infections (HP:0001581) | 3.39866460 |
| 36 | Urticaria (HP:0001025) | 3.37597875 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.27905297 |
| 38 | Stomatitis (HP:0010280) | 3.22011985 |
| 39 | * Lymphopenia (HP:0001888) | 3.21369703 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21129430 |
| 41 | Obstructive lung disease (HP:0006536) | 3.21129430 |
| 42 | Chronic sinusitis (HP:0011109) | 3.19449130 |
| 43 | Vasculitis (HP:0002633) | 3.18787543 |
| 44 | Keratoconjunctivitis (HP:0001096) | 3.17026844 |
| 45 | Colitis (HP:0002583) | 3.15984298 |
| 46 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.15646978 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 3.14988946 |
| 48 | Pustule (HP:0200039) | 3.09815646 |
| 49 | Papilloma (HP:0012740) | 3.09750788 |
| 50 | Verrucae (HP:0200043) | 3.09750788 |
| 51 | Spontaneous hematomas (HP:0007420) | 3.05119096 |
| 52 | Hypochromic anemia (HP:0001931) | 2.97994212 |
| 53 | Bronchitis (HP:0012387) | 2.96461657 |
| 54 | Eosinophilia (HP:0001880) | 2.94359675 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.87226859 |
| 56 | Abnormality of eosinophils (HP:0001879) | 2.87141346 |
| 57 | Chronic diarrhea (HP:0002028) | 2.86985244 |
| 58 | Abnormality of the fingertips (HP:0001211) | 2.77690490 |
| 59 | Leukocytosis (HP:0001974) | 2.77666735 |
| 60 | Granulocytopenia (HP:0001913) | 2.77371875 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.74341290 |
| 62 | Lymphoma (HP:0002665) | 2.72837403 |
| 63 | Encephalitis (HP:0002383) | 2.71856308 |
| 64 | Petechiae (HP:0000967) | 2.68311520 |
| 65 | IgA deficiency (HP:0002720) | 2.67860829 |
| 66 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67458972 |
| 67 | Increased IgE level (HP:0003212) | 2.60597248 |
| 68 | Pulmonary embolism (HP:0002204) | 2.56482251 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.54786193 |
| 70 | Episodic fever (HP:0001954) | 2.54306888 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.54069829 |
| 72 | Abnormality of macrophages (HP:0004311) | 2.53776396 |
| 73 | Osteomyelitis (HP:0002754) | 2.44728998 |
| 74 | Anorexia (HP:0002039) | 2.44724867 |
| 75 | Emphysema (HP:0002097) | 2.43555556 |
| 76 | Gingival bleeding (HP:0000225) | 2.42870207 |
| 77 | Orchitis (HP:0100796) | 2.41838865 |
| 78 | Hypoplasia of the thymus (HP:0000778) | 2.41782068 |
| 79 | Hemoptysis (HP:0002105) | 2.39982919 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 2.39721496 |
| 81 | Optic neuritis (HP:0100653) | 2.38456807 |
| 82 | Retrobulbar optic neuritis (HP:0100654) | 2.38456807 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.37026660 |
| 84 | Epistaxis (HP:0000421) | 2.34014666 |
| 85 | Abnormality of the pleura (HP:0002103) | 2.33738526 |
| 86 | Basal cell carcinoma (HP:0002671) | 2.29125726 |
| 87 | Chest pain (HP:0100749) | 2.28694852 |
| 88 | Sepsis (HP:0100806) | 2.27672374 |
| 89 | Recurrent lower respiratory tract infections (HP:0002783) | 2.25931635 |
| 90 | Recurrent pneumonia (HP:0006532) | 2.24120432 |
| 91 | Microcytic anemia (HP:0001935) | 2.23906665 |
| 92 | Pulmonary infiltrates (HP:0002113) | 2.23610339 |
| 93 | Skin ulcer (HP:0200042) | 2.20991332 |
| 94 | Recurrent otitis media (HP:0000403) | 2.17263894 |
| 95 | Gangrene (HP:0100758) | 2.16606260 |
| 96 | Acute hepatic failure (HP:0006554) | 2.16149897 |
| 97 | Gingivitis (HP:0000230) | 2.14210309 |
| 98 | Increased IgM level (HP:0003496) | 2.13960876 |
| 99 | Viral hepatitis (HP:0006562) | 2.13625340 |
| 100 | Skin rash (HP:0000988) | 2.09048210 |
| 101 | Poikiloderma (HP:0001029) | 2.07655918 |
| 102 | Glomerulopathy (HP:0100820) | 2.05032527 |
| 103 | Purpura (HP:0000979) | 2.04921661 |
| 104 | Abnormality of the prostate (HP:0008775) | 2.04836855 |
| 105 | Joint swelling (HP:0001386) | 2.04094094 |
| 106 | Premature loss of primary teeth (HP:0006323) | 2.03576913 |
| 107 | Restrictive lung disease (HP:0002091) | 2.02932483 |
| 108 | Reticulocytopenia (HP:0001896) | 2.02785867 |
| 109 | Periodontitis (HP:0000704) | 2.01427716 |
| 110 | Arterial thrombosis (HP:0004420) | 2.00875316 |
| 111 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00567672 |
| 112 | Hepatosplenomegaly (HP:0001433) | 1.98039930 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 1.97878208 |
| 114 | Slow saccadic eye movements (HP:0000514) | 1.97026772 |
| 115 | Keratoconjunctivitis sicca (HP:0001097) | 1.96292953 |
| 116 | Papilledema (HP:0001085) | 1.95809480 |
| 117 | Abnormal platelet volume (HP:0011876) | 1.93465223 |
| 118 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.92902457 |
| 119 | Neutropenia (HP:0001875) | 1.92420050 |
| 120 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.92336616 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.91150672 |
| 122 | Abnormal platelet function (HP:0011869) | 1.91150672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.80727533 |
| 2 | TXK | 3.34623346 |
| 3 | PRPF4B | 2.91866994 |
| 4 | ZAP70 | 2.82051959 |
| 5 | BLK | 2.77405033 |
| 6 | JAK3 | 2.61409491 |
| 7 | KIT | 2.45955415 |
| 8 | TYK2 | 2.45141509 |
| 9 | GRK6 | 2.40212799 |
| 10 | STK10 | 2.38046956 |
| 11 | BTK | 2.37029765 |
| 12 | EEF2K | 2.21561229 |
| 13 | ITK | 2.20725447 |
| 14 | MAP3K10 | 2.11732722 |
| 15 | IKBKE | 2.11590553 |
| 16 | SYK | 2.10349473 |
| 17 | TEC | 2.10078705 |
| 18 | CSF1R | 2.04560683 |
| 19 | IRAK4 | 1.99572665 |
| 20 | TBK1 | 1.91102734 |
| 21 | TESK2 | 1.76441847 |
| 22 | FGFR4 | 1.74517877 |
| 23 | LCK | 1.68064286 |
| 24 | CLK1 | 1.57380293 |
| 25 | MAP3K14 | 1.56048250 |
| 26 | LRRK2 | 1.54775562 |
| 27 | JAK1 | 1.51040161 |
| 28 | KDR | 1.50369892 |
| 29 | NME2 | 1.49570545 |
| 30 | FLT3 | 1.49191183 |
| 31 | FES | 1.47235660 |
| 32 | HCK | 1.44782288 |
| 33 | CSK | 1.41271393 |
| 34 | PKN2 | 1.35743084 |
| 35 | ERN1 | 1.34372043 |
| 36 | SMG1 | 1.31247578 |
| 37 | FGR | 1.29981697 |
| 38 | NLK | 1.26286046 |
| 39 | MAP3K3 | 1.25704048 |
| 40 | MAP3K13 | 1.25486633 |
| 41 | LYN | 1.24003671 |
| 42 | RIPK4 | 1.20252215 |
| 43 | FGFR3 | 1.20119088 |
| 44 | MAP2K3 | 1.12453728 |
| 45 | IKBKB | 1.06186308 |
| 46 | SIK2 | 1.03127459 |
| 47 | RPS6KA4 | 1.00501996 |
| 48 | MAP3K1 | 0.99739322 |
| 49 | TGFBR2 | 0.99643680 |
| 50 | TRIB3 | 0.97804280 |
| 51 | PIM1 | 0.94724771 |
| 52 | MST4 | 0.93244918 |
| 53 | KSR2 | 0.91324315 |
| 54 | MARK3 | 0.89633669 |
| 55 | MAP3K12 | 0.87727459 |
| 56 | TNK2 | 0.86240464 |
| 57 | NEK2 | 0.85454458 |
| 58 | MARK2 | 0.85207683 |
| 59 | YES1 | 0.84727181 |
| 60 | PRKCH | 0.83219717 |
| 61 | PRKD2 | 0.81246362 |
| 62 | TAOK2 | 0.79496722 |
| 63 | CDC7 | 0.78455534 |
| 64 | TGFBR1 | 0.77947846 |
| 65 | PRKCQ | 0.77250992 |
| 66 | ACVR1B | 0.77211976 |
| 67 | PTK6 | 0.71200127 |
| 68 | CDK4 | 0.70493896 |
| 69 | SIK3 | 0.69069193 |
| 70 | BMPR2 | 0.68938426 |
| 71 | JAK2 | 0.66928526 |
| 72 | CAMKK1 | 0.65515810 |
| 73 | PDPK1 | 0.61512211 |
| 74 | EPHB1 | 0.59850082 |
| 75 | MAPK7 | 0.59710970 |
| 76 | STK4 | 0.59227563 |
| 77 | CDC42BPA | 0.57458145 |
| 78 | SCYL2 | 0.56613798 |
| 79 | BUB1 | 0.55791328 |
| 80 | MAPK11 | 0.55611271 |
| 81 | SIK1 | 0.55153363 |
| 82 | IRAK1 | 0.50414779 |
| 83 | RPS6KB2 | 0.49947980 |
| 84 | MAPK4 | 0.49898420 |
| 85 | PDK1 | 0.49852907 |
| 86 | PASK | 0.46191553 |
| 87 | CAMKK2 | 0.45788125 |
| 88 | EIF2AK3 | 0.45547448 |
| 89 | MAP3K8 | 0.45470185 |
| 90 | CHUK | 0.44794750 |
| 91 | MAP3K6 | 0.42757992 |
| 92 | STK11 | 0.42530449 |
| 93 | IRAK3 | 0.41940539 |
| 94 | HIPK2 | 0.41227353 |
| 95 | TAOK3 | 0.41020974 |
| 96 | ATR | 0.40150661 |
| 97 | MAP3K7 | 0.39364436 |
| 98 | DYRK1B | 0.39098486 |
| 99 | TLK1 | 0.38755488 |
| 100 | PIK3CG | 0.38469935 |
| 101 | MAP3K5 | 0.38389866 |
| 102 | TAOK1 | 0.38183690 |
| 103 | ALK | 0.38068305 |
| 104 | IRAK2 | 0.37974086 |
| 105 | CCNB1 | 0.37968171 |
| 106 | PIM2 | 0.37811200 |
| 107 | MAP3K11 | 0.37507161 |
| 108 | RET | 0.35722523 |
| 109 | RPS6KA6 | 0.35405499 |
| 110 | EPHA3 | 0.32688207 |
| 111 | MAPKAPK2 | 0.32606450 |
| 112 | FYN | 0.32366976 |
| 113 | RAF1 | 0.32366036 |
| 114 | MAP2K2 | 0.32139419 |
| 115 | MAP2K6 | 0.32008424 |
| 116 | TESK1 | 0.30482002 |
| 117 | ADRBK2 | 0.30409017 |
| 118 | MATK | 0.29925929 |
| 119 | PTK2B | 0.29440484 |
| 120 | DAPK1 | 0.29413756 |
| 121 | MAPK12 | 0.28872665 |
| 122 | TRPM7 | 0.28017514 |
| 123 | WEE1 | 0.27783419 |
| 124 | PRKCD | 0.27754995 |
| 125 | SGK3 | 0.25767217 |
| 126 | RPS6KL1 | 0.23836539 |
| 127 | RPS6KC1 | 0.23836539 |
| 128 | ABL1 | 0.23523717 |
| 129 | CDK19 | 0.23372688 |
| 130 | TTN | 0.22750242 |
| 131 | CDK12 | 0.22038573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.20749801 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.80674395 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.62304901 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.51856767 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.51721650 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45491889 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.42377747 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.36641829 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.36517877 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35565382 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30606898 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.19568440 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01261550 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.88665608 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84593268 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 1.84221387 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.75668103 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74926816 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.71326197 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.68523670 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.67075459 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62964154 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56392534 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.54723668 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.52066207 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41414204 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38291305 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35221975 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32085753 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28343109 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.27259907 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.24608326 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.23750118 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23280381 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.22041674 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21231717 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21209253 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.15112146 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.13147428 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.12753079 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.11518496 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07449793 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.07003171 |
| 44 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06505168 |
| 45 | * Phagosome_Homo sapiens_hsa04145 | 1.05083438 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.02510062 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02345474 |
| 48 | * Tuberculosis_Homo sapiens_hsa05152 | 1.00850991 |
| 49 | Asthma_Homo sapiens_hsa05310 | 0.99880250 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.99648144 |
| 51 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97762142 |
| 52 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95487519 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94943401 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90160557 |
| 55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90059951 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89953684 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.89086135 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 0.88732721 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87760762 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86394491 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82149131 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81502791 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.78357459 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77378461 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 0.76902038 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76444204 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74968742 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74122353 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74008774 |
| 70 | Proteasome_Homo sapiens_hsa03050 | 0.73203369 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72297882 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.68286565 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67385158 |
| 74 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63623570 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63371531 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63032657 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62690756 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62664348 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.60124525 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59626537 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.56482013 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55016721 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52580005 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51670893 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51135868 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50976982 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49639204 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47935353 |
| 89 | RNA transport_Homo sapiens_hsa03013 | 0.47578293 |
| 90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43019617 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41988920 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.41843762 |
| 93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40569926 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40396835 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37873454 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37613416 |
| 97 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37607447 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36334154 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.35452543 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35387859 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34487438 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33594376 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32579638 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.32178208 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.31677402 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31621279 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31322822 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31255077 |
| 109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.31018614 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30730715 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30713012 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30525201 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29822674 |
| 114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29564727 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.29548585 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28763622 |
| 117 | RNA polymerase_Homo sapiens_hsa03020 | 0.28577419 |
| 118 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28573940 |
| 119 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.28535052 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.27531723 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26284827 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25624295 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25419433 |
| 124 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24719244 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23806699 |
| 126 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.23686763 |

